# Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)

> **NCT00926055** · NA · WITHDRAWN · sponsor: **Korea University**

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** Ezetrol (Ezetimibe)
- **DRUG:** Vytorin (Ezetimibe + Simvastatin)

## Key facts

- **NCT ID:** NCT00926055
- **Lead sponsor:** Korea University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-09
- **Primary completion:** 2012-09
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926055, "Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)". Retrieved via MORVS 2026-10-30 from https://api.morvs.ai/clinical/NCT00926055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*